Estradiol
Product Images NDC 53002-1807

Product Visual Gallery

This gallery contains 17 technical images submitted to the FDA as part of the official labeling for Estradiol (NDC 53002-1807). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rpk Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Estradiol Structural Formula (Image 01)

Chemical structure diagram of Estradiol, showing the molecular arrangement including hydroxyl groups and methyl substituents.*

FDA Label Image

Estradiol Transdermal System (Layers)

FDA Label Image

Figure 1 Steady-state Estradiol Plasma Concentrations For Systems Applied To The Abdomen (Image 03)

A line graph showing estradiol concentration (pg/mL) over time (days) for different dosage levels. The graph compares concentration profiles for 0.1 mg/day, 0.075 mg/day, 0.05 mg/day, and 0.0375 mg/day doses, with concentration measured on the vertical axis and time on the horizontal axis.*

FDA Label Image

Figure 2 Mean (sd) Change From Baseline In Mean Daily Number (Image 04)

Bar chart comparing mean (SD) reduction from baseline at weeks 4, 8, and 12 between Estradiol 0.0375 mg/day and placebo. Estradiol shows greater reduction at each time point with data for sample sizes noted. Statistical significance between estradiol and placebo is indicated (p<0.05).*

FDA Label Image

Figure 3 Bone Mineral Density (Image 05)

A line graph showing percentage change from baseline over treatment duration in weeks (26 to 104) for Estradiol doses 0.1 mg/day, 0.05 mg/day, 0.0375 mg/day, 0.025 mg/day, and placebo. The x-axis represents treatment duration in weeks, and the y-axis represents percentage change from baseline. Each dose is represented by a distinct line type and marker.*

FDA Label Image

Figure 4 Bone Mineral Density (Image 06)

A line graph depicting the percent change from baseline over a treatment duration of 104 weeks for Estradiol at doses 0.1 mg/day, 0.05 mg/day, 0.0375 mg/day, 0.025 mg/day, and a placebo. The graph includes statistical significance annotations comparing the groups at various weeks.*

FDA Label Image

Estradiol Transdermal System (Calendar)

A text panel titled 'Estradiol Transdermal System' explaining patch change schedules. It lists paired days of the week for changing the patch: Sun/Wed, Mon/Thu, Tue/Fri, Wed/Sat, Thu/Sun, Fri/Mon, and Sat/Tue, with checkboxes beside each pair. No dosage or other information visible.*

FDA Label Image

Where To Apply Estradiol Transdermal System (Image 08)

An illustration showing a human abdomen with a hand holding a rectangular patch, positioned as if applying it to the skin. This likely represents the application of a transdermal patch, possibly related to the Estradiol product from RPK Pharmaceuticals, Inc.*

FDA Label Image

Before You Apply Estradiol Transdermal System (Image 09)

FDA Label Image

Hows To Apply Estradiol Transdermal System (1)

An instructional illustration showing two hands, one holding a small rectangular object, and the other peeling or removing part of the object. The image likely demonstrates how to open or use a product, related to Estradiol by RPK Pharmaceuticals, Inc.*

FDA Label Image

How To Apply Estradiol Transdermal System (2)

An instructional line drawing depicting two hands peeling apart a single dose strip, demonstrating how to open a unit dose pack for drug administration or use. The image shows the fingers gripping and pulling the edges of the strip to separate it.*

FDA Label Image

How To Apply Estradiol Transdermal System (3)

Illustration showing a hand using one finger to apply a small adhesive patch onto the skin of the lower abdomen, likely demonstrating the application site for a transdermal product.*

FDA Label Image

How To Apply Estradiol Transdermal System (4)

An instructional diagram showing how to apply a small adhesive patch to the skin using fingers. One hand holds the patch while the other hand presses it down to secure it in place.*

FDA Label Image

How To Apply Estradiol Transdermal System (5)

An instructional illustration showing a hand holding a small testing device while the other hand places a finger on it, likely demonstrating how to use a blood glucose or similar testing device.*

FDA Label Image

How To Apply Estradiol Transdermal System (6)

An illustration showing the back of a left hand with a small drop above the skin near the base of the middle finger, indicating a site for topical application.*

FDA Label Image

How To Apply Estradiol Transdermal System (7)

An instructional illustration showing a hand using a finger to apply a medication patch onto the skin of the lower abdominal area. The diagram highlights the patch placement process for topical drug administration.*

FDA Label Image

Label Image (Lbl530021807)

Packaging label for Estradiol Transdermal System 0.05 mg, a patch product by RPK Pharmaceuticals, Inc. The label indicates application instructions as 'Apply patch twice a week' with 8 patches per package. It includes directions, lot number, expiration date, and spaces for patient and prescriber information.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.